Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women

BACKGROUND: Every 2 minutes there is a pregnancy related death worldwide, with one third due to severe postpartum hemorrhage (PPH). While international trials demonstrated efficacy of 1,000 mg TXA in treating PPH, to our knowledge there are no dose finding studies of TXA in pregnant women for PPH pr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Obstet Gynecol
Hlavní autoři: AHMADZIA, Homa K., LUBAN, Naomi L.C., LI, Shuhui, GUO, Dong, MISZTA, Adam, GOBBURU, Jogarao V.S., BERGER, Jeffrey S., JAMES, Andra H., WOLBERG, Alisa S., VAN DEN ANKER, John
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8149481/
https://ncbi.nlm.nih.gov/pubmed/33248975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2020.11.035
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky